Bilirubin Increases the Risk of Nosocomial Infection in Cirrhotic Patients

NCT05752084 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2023-03-06

No results posted yet for this study

Summary

Nosocomial infection (NIs) is a major challenge in healthcare facilities and has been associated with prolonged hospital stay as well as increased morbidity and mortality.

This research aimed to estimate the impact of acute decompensation (AD) consequences on the successive risk of nosocomial infections (NIs) and the go after outcome.

Conditions

  • Nosocomial Infection

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-11-01
Completion
2022-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05752084 on ClinicalTrials.gov